Jacob A. Udell
Jacob A. Udell
Verified email at
Cited by
Cited by
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ...
New England Journal of Medicine 369 (14), 1317-1326, 2013
Sotagliflozin in patients with diabetes and chronic kidney disease
DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ...
New England Journal of Medicine 384 (2), 129-139, 2021
Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial
BM Scirica, E Braunwald, I Raz, MA Cavender, DA Morrow, P Jarolim, ...
Circulation 130 (18), 1579-1588, 2014
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis
JA Udell, R Zawi, DL Bhatt, M Keshtkar-Jahromi, F Gaughran, ...
Jama 310 (16), 1711-1720, 2013
Sodium glucose cotransporter-2 inhibition in heart failure: potential mechanisms, clinical applications, and summary of clinical trials
Y Lytvyn, P Bjornstad, JA Udell, JA Lovshin, DZI Cherney
Circulation 136 (17), 1643-1658, 2017
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative metaá…
JA Udell, MP Bonaca, JP Collet, AM Lincoff, DJ Kereiakes, F Costa, ...
European heart journal 37 (4), 390-399, 2016
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
JA Udell, MA Cavender, DL Bhatt, S Chatterjee, ME Farkouh, BM Scirica
The lancet Diabetes & endocrinology 3 (5), 356-366, 2015
Does this patient with liver disease have cirrhosis?
JA Udell, CS Wang, J Tinmouth, JM FitzGerald, NT Ayas, DL Simel, ...
Jama 307 (8), 832-842, 2012
A multicenter observational study of incretin-based drugs and heart failure
KB Filion, L Azoulay, RW Platt, M Dahl, CR Dormuth, KK Clemens, N Hu, ...
New England Journal of Medicine 374 (12), 1145-1154, 2016
Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence forá…
JA Udell, Z Yuan, T Rush, NM Sicignano, M Galitz, N Rosenthal
Circulation 137 (14), 1450-1459, 2018
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial
JA Udell, DL Bhatt, E Braunwald, MA Cavender, O Mosenzon, PG Steg, ...
Diabetes care 38 (4), 696-705, 2015
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
BM Hicks, KB Filion, H Yin, L Sakr, JA Udell, L Azoulay
bmj 363, 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy
SR Mehta, KR Bainey, WJ Cantor, M LordkipanidzÚ, G Marquis-Gravel, ...
Canadian Journal of Cardiology 34 (3), 214-233, 2018
The Cardiovascular Health in Ambulatory Care Research Team (CANHEART) using big data to measure and improve cardiovascular health and healthcare services
JV Tu, A Chu, LR Donovan, DT Ko, GL Booth, K Tu, LC Maclagan, H Guo, ...
Circulation: Cardiovascular Quality and Outcomes 8 (2), 204-212, 2015
Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial
O Vardeny, B Claggett, JA Udell, M Packer, M Zile, J Rouleau, ...
JACC: Heart Failure 4 (2), 152-158, 2016
Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis
JA Udell, PG Steg, BM Scirica, SC Smith, EM Ohman, KA Eagle, S Goto, ...
Archives of internal medicine 172 (14), 1086-1095, 2012
The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study
BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ...
American Heart Journal 162 (5), 818-825. e6, 2011
Association of influenza-like illness activity with hospitalizations for heart failure: the atherosclerosis risk in communities study
S Kyt÷maa, S Hegde, B Claggett, JA Udell, W Rosamond, J Temte, ...
JAMA cardiology 4 (4), 363-369, 2019
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review andá…
OR Ghosh-Swaby, SG Goodman, LA Leiter, A Cheng, KA Connelly, ...
The lancet Diabetes & endocrinology 8 (5), 418-435, 2020
Heart failure outcomes in clinical trials of glucose‐lowering agents in patients with diabetes
DH Fitchett, JA Udell, SE Inzucchi
European journal of heart failure 19 (1), 43-53, 2017
The system can't perform the operation now. Try again later.
Articles 1–20